ATPγS (tetralithium salt)
ATPγS (tetralithium salt) is a P2Y11 receptor agonist, an antioxidant and a neuroprotective agent. ATPγS (tetralithium salt) can be used as a substrate for the nucleotide hydrolysis and RNA unwinding activities of eukaryotic translation initiation factor eIF4A. ATPγS (tetralithium salt) is active in ATP hydrolysis[1][2][3][4][5].
Product Specifications
CAS Number
[93839-89-5]
Product Name Alternative
Adenosine-5'-O- (3-thiotriphosphate) (tetralithium salt) ; Adenosine 5'-[γ-thio]triphosphate (tetralithium salt)
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Eukaryotic Initiation Factor (eIF) ; P2Y Receptor
Related Pathways
Cell Cycle/DNA Damage; GPCR/G Protein
Applications
COVID-19-anti-virus
Field of Research
Metabolic Disease; Inflammation/Immunology; Neurological Disease
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 75 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@@H](O[C@H](COP(OP(OP(O[Li])(O[Li])=S)(O[Li])=O)(O[Li])=O)[C@H]1O)N2C3=C(C(N)=NC=N3)N=C2
Molecular Formula
C10H12Li4N5O12P3S
Molecular Weight
546.98
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EIF4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items